1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Japan Pharmaceuticals and Healthcare Report Q4 2016

Japan Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 126 pages

Includes 3 FREE quarterly updates



BMI View: Competition in the Japanese biosimilar market is set to intensify over the coming years.Fundamentals attracting drugmakers into this field include its relatively nascent state, with few biosimilarslaunched thus far, cost containment pressures and well-defined regulations that will facilitate market entry.We expect branding to be a key differentiator in this medicine class, as it will require pharmaceutical firmsto actively engage stakeholders, especially doctors.

Headline Expenditure Projections

- Pharmaceuticals: JPY11.5trn (USD94.9bn) in 2015 to JPY11.7trn (USD109.7bn) by 2016 with a y-o-ygrowth of 2.2% in local currency terms and 15.6% in USD terms. Local currency forecast unchangedfrom last quarter, though a strengthening of the yen has shifted US dollar values.

- Healthcare: JPY50.8trn (USD419.4bn) in 2015 to JPY51.7trn (USD482.9bn) in 2016 with a y-o-ygrowth of 1.8% in local currency terms and 15.1% in USD terms. The US dollar amount remains volatileand will be contingent on the Bank of Japan's decision to weaken the currency having recentlyimplemented negative interest rates.

Table Of Contents

Japan Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Japan 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Japan 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Japan 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Japan 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Japan 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Japan 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Japan 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Japan 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Japan 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Japan 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Japan 2014-2020) 30
Industry Risk Reward Index 31
Asia Pacific Risk/Reward Index - Q4 2016 31
Japan Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Table: Re-examination Period 45
Pricing and Reimbursement 45
Table: Market Expansion Re-Pricing Formulas 47
Market Overview 48
Healthcare Sector 48
Table: Healthcare Resources (Japan 2010-2015) 49
Table: Healthcare Personnel (Japan 2010-2015) 50
Table: Healthcare Activity (Japan 2010-2015) 50
Research and Development 50
Clinical Trials 51
Epidemiology 52
Table: Estimated Number Of New Cases Of Cancer In Japan 54
Table: Japan: Dementia Cases And Types Across Different Areas 55
Competitive Landscape 57
Research-Based Industry 57
Table: Companies Represented By The JPMA 57
Table: Multinational Pharmaceutical Firm Activity 58
Generic Drug Industry 61
Table: Members Of The Japan Generic Medicines Association 61
Pharmaceutical Distribution 62
Pharmaceutical Retail Sector 63
Company Profile 65
Astellas 65
AstraZeneca 71
Daiichi Sankyo 74
Eisai 78
GlaxoSmithKline 84
Merck and Co 88
Mitsubishi Tanabe 91
Novartis 94
Pfizer 99
Sanofi 103
Sawai Pharmaceutical 107
Takeda Pharmaceutical Company 110
Demographic Forecast 115
Demographic Outlook 115
Table: Population Headline Indicators (Japan 1990-2025) 116
Table: Key Population Ratios (Japan 1990-2025) 116
Table: Urban/Rural Population and Life Expectancy (Japan 1990-2025) 117
Table: Population By Age Group (Japan 1990-2025) 117
Table: Population By Age Group % (Japan 1990-2025) 118
Glossary 120
Methodology 122
Pharmaceutical Expenditure Forecast Model 122
Healthcare Expenditure Forecast Model 122
Notes On Methodology 123
Risk/Reward Index Methodology 124
Index Overview 125
Table: Pharmaceutical Risk/Reward Index Indicators 125
Indicator Weightings 126

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.